XML 65 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1
Development Liability - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 8 Months Ended 12 Months Ended
May 13, 2024
May 31, 2024
Mar. 31, 2024
Jan. 31, 2020
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Proceeds from credit facility         $ 365,454      
Loss on extinguishment of development liability         1,949      
Interest expense         40,391 $ 29,581 $ 32,626  
Sixth Financing Agreement [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Proceeds from credit facility $ 326,500 $ 326,500            
SFJ Agreement [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Proceeds from SFJ agreement       $ 140,000        
Payment made under agreement     $ 94,000          
Loss on extinguishment of development liability         1,900      
Interest expense         8,900 $ 26,000 $ 26,900  
Development liability reacquisition price         326,500      
Development liability carrying value         $ 324,600      
SFJ Agreement [Member] | Regulatory Approval Granted US Food and Drug Administration [Member]                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Obligated to pay initial payment               $ 460,000